![Christine Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Murray
General Counsel bei
CYTOKINETICS, INCORPORATED
Profil
Christine Murray currently works at Cytokinetics, Inc., as Senior Vice President-Regulatory & Quality from 2023.
Ms. Murray also formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2019 to 2024, Achaogen, Inc., as Vice President-Regulatory Affairs from 2011 to 2015, Horizon Pharmaceutical LLC, as Vice President-Global Regulatory Affairs from 2015 to 2017, Raptor Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 2015 to 2017, and Ultragenyx Pharmaceutical, Inc., as Senior Vice President-Global Regulatory Affairs from 2018 to 2021.
Ms. Murray received her undergraduate degree from The University of Liverpool and graduate degree from Newcastle University.
Aktive Positionen von Christine Murray
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | General Counsel | 01.04.2023 |
Ehemalige bekannte Positionen von Christine Murray
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Direktor/Vorstandsmitglied | 15.03.2024 |
| ULTRAGENYX PHARMACEUTICAL INC. | General Counsel | 01.09.2021 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Corporate Officer/Principal | 01.02.2017 |
| RAPTOR PHARMACEUTICAL CORP | General Counsel | 01.01.2017 |
| ACHAOGEN | General Counsel | 02.01.2015 |
Ausbildung von Christine Murray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University
 Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
